Sort
16,300 grants matching “fatty liver disease”
Lipid and Lipoprotein Metabolism in Atherosclerosis
$2,310,000Alan M Fogelman · University Of California Los Angeles · P01 · FY2015 · HL
Hepatobiology and Toxicology COBRE
$2,309,596Craig J McClain · University Of Louisville · P20 · FY2022 · GM
Endocannabinoids And Energy Homeostasis
$2,308,469George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
$2,305,521Andreas Stahl · University Of California Berkeley · UH3 · FY2020 · DK
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)
$2,304,661Kabayam M Venkat Narayan · Emory University · P01 · FY2025 · HL
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,303,826Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2020 · HL
Role of hypernutrition and metabolic stress in non-alcoholic steatohepatitis (NASH) driven hepatocellular carcinoma (HCC)
$2,302,833Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · CA
Characterization of the Fetal Primate Epigenome and Metabolome Under In Utero
$2,302,500Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · DP2 · FY2007 · OD
Transformed Probiotic Bacteria for Treatment of Chronic Diseases
$2,302,500Sean Stephen Davies · Vanderbilt University · DP2 · FY2007 · OD
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)
$2,301,664Kabayam M Venkat Narayan · Emory University · P01 · FY2022 · HL
Molecular mechanisms and pathways of novel genomic loci regulating plasma lipids
$2,300,000Daniel James Rader · University Of Pennsylvania · RC2 · FY2010 · HL
Center for Childhood Obesity Prevention
$2,297,175Judith Lynne Weber · Arkansas Children'S Hospital Res Inst · P20 · FY2023 · GM
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,296,647Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Center for Childhood Obesity Prevention
$2,296,429Elisabet Borsheim · Arkansas Children'S Hospital Res Inst · P20 · FY2024 · GM
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
$2,294,476Andreas Stahl · University Of California Berkeley · UH3 · FY2021 · DK
Center for Childhood Obesity Prevention
$2,292,891Judith Lynne Weber · Arkansas Children'S Hospital Res Inst · P20 · FY2022 · GM
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)
$2,289,655Kabayam M Venkat Narayan · Emory University · P01 · FY2023 · HL
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
$2,287,847Andreas Stahl · University Of California Berkeley · UH3 · FY2022 · DK
HORMONAL REGULATION OF BLOOD PRESSURE
$2,285,707Michal Laniado Schwartzman · New York Medical College · P01 · FY2012 · HL
Genetics of Brain Development
$2,281,396Maximilian Muenke · National Human Genome Research Institute · ZIA · FY2018 · HG
Hepatobiology and Toxicology COBRE
$2,279,140Craig J McClain · University Of Louisville · P20 · FY2017 · GM
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,278,867Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2021 · HL
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,278,344Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
HDL Structure and its Function in Atherosclerosis
$2,277,257Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2014 · HL
A multifaceted approach to target obesity
$2,277,000Satyanarayana Ande · Augusta University · DP2 · FY2014 · DK